Evidence-Based Complementary and Alternative Medicine / 2016 / Article / Tab 1

Research Article

The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis

Table 1

Characteristics of the 6 included studies.

StudySample size, Intervention of experimental groupIntervention of control groupDose of berberineDurationOutcomes

Bai et al. 2011 [16]78BBRISI0.5 g, tid3 months1, 2, 3, 5, 6, 7, 8, 11
Cao et al. 2012 [17]78BBR + metforminMetformin0.5 g, tid16 weeks1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Li 2015 [18]96BBRAcarbose0.3 g, tid3 months1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Ning et al. 2013 [19]44BBR + metforminMetformin0.5 g, tid16 weeks1, 2, 8, 10
Xie et al. 2011 [20]60BBRXuezhikang0.3 g, tid12 weeks1, 2, 3, 4, 5, 6
Yan et al. 2015 [21]155BBRISI or pioglitazone0.5 g, tid16 weeks1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11

1: TC; 2: TG; 3: LDL; 4: HDL; 5: ALT; 6: AST; 7: GGT; 8: FBG; 9: 2hPG; 10: HbA1c; 11: HOMA-IR.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.